In conclusion, IQGAP1 mediates tumor drug resistance through multiple mechanisms, including the suppression of ferroptosis via YAP activation, ROS-induced Src/FAK signaling, sustained MAPK activation, and ARF1-IQGAP1 complex-driven ERK activation. This evidence concerns the gene ARF1 and neoplasm.